Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
TVTX
Stock Latest News
Ratings
Buy Rating for Travere Therapeutics: Strong Market Position and Growth Potential with Filspari and FSGS Expansion
24d ago
TVTX
Premium
Ratings
Buy Rating on Travere Therapeutics: Undervaluation Amidst IgAN and FSGS Opportunities
1M ago
TVTX
Premium
The Fly
Travere Therapeutics asumed with a Buy at H.C. Wainwright
1M ago
TVTX
Premium
Ratings
Buy Rating for Travere Therapeutics: Anticipated FDA Approval and Strategic Developments Signal Significant Upside Potential
1M ago
TVTX
Premium
The Fly
Citi trims Travere target, opens ‘upside 90-day catalyst watch’
1M ago
TVTX
Premium
The Fly
Cito trims Travere target, opens ‘upside 90-day catalyst watch’
1M ago
TVTX
Premium
Ratings
Buy Rating for Travere Therapeutics Amid Filspari’s FDA Review and Market Potential
2M ago
TVTX
Premium
Company Announcements
Travere Therapeutics Holds Annual Meeting, Elects Directors
2M ago
8K
TVTX
Premium
Ratings
Buy Rating for Travere Therapeutics: Strong Potential in FSGS Market Amidst Regulatory Milestones and Competitive Edge
2M ago
TVTX
Premium
The Fly
Travere falls 14% to $18.10 after FDA does not grant priority review
2M ago
TVTX
Premium
The Fly
Travere Therapeutics selloff should be bought, says Citi
2M ago
TVTX
Premium
Ratings
Buy Rating Reaffirmed for Travere Therapeutics Amid FDA Review and Market Overreaction
2M ago
TVTX
Premium
The Fly
Closing Bell Movers: Applied Materials down over 5% after Q2 results
2M ago
QSI
AMAT
Premium
Company Announcements
Travere Therapeutics’ FDA Acceptance for FILSPARI Application
2M ago
8K
TVTX
Premium
The Fly
Travere Therapeutics announces FDA acceptance of sNDA for Filspari
2M ago
TVTX
Premium
Ratings
Travere Therapeutics: Strong Market Position and Growth Potential Drive Buy Rating
2M ago
TVTX
Premium
Company Announcements
Travere Therapeutics’ Earnings Call: Growth Amid Challenges
3M ago
TVTX
Premium
Company Announcements
Travere Therapeutics Reports Strong Q1 2025 Financial Results
3M ago
TVTX
Premium
Ratings
Strong Market Performance and Growth Potential Drive Buy Rating for Travere Therapeutics
3M ago
TVTX
Premium
The Fly
Travere Therapeutics reports Q1 adjusted EPS (19c), consensus (39c)
3M ago
TVTX
Premium
The Fly
Travere, CSL Vifor report EC approval of Filspari for IgA nephropathy
3M ago
TVTX
Premium
The Fly
Travere, CSL Vifor announce EC approval of Filspari marketing authorization
3M ago
TVTX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
